Immuneering Corp (IMRX): Total Liabilities
$13.50M
As of 2025-12-31
$11.32M
As of 2026-06-30
+2.6%
3-year compound annual growth
+37.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.50M | +19.2% | 2026-03-06, Balance as of period end |
| 2024-12-31 | $11.33M | -5.7% | 2026-03-06, Balance as of period end |
| 2023-12-31 | $12.01M | -4.1% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $12.52M | +16.7% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $10.72M | +282.9% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $2.80M | n/a | 2022-03-10, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Immuneering Corp (IMRX) | 2025-12-31 | $13.50M | +19.2% |
| Design Therapeutics, Inc. (DSGN) | 2025-12-31 | $13.70M | +37.1% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $248.97M | +9.7% |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | $44.02M | -52.6% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $19.38M | -32.0% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $191.91M | -4.1% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $37.28M | -20.8% |
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | $60.35M | -7.0% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $20.65M | -27.6% |
Compare IMRX, DSGN, EOLS, PLRX side by side · Screen every company in Pharmaceutical Preparations ↗